Antonio Boza-Serrano

3PUBLICATIONS
0CO-AUTHORS
Chemical engineering designInstrumental methods (excl. immunological and bioassay methods)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 15, 2023
Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.

Antonio Boza-Serrano, Rocío Ruiz, Raquel Sanchez-Varo

|Jul 27, 2022
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer's disease.

Antonio Boza-Serrano, Agathe Vrillon, Karolina Minta

|Apr 22, 2019
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.

Antonio Boza-Serrano, Rocío Ruiz, Raquel Sanchez-Varo

Pageof 1

Frequent Collaborators